P8IP
INSM icon

Pier 88 Investment Partners’s Insmed INSM Stock Holding History

Pier 88 Investment Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,200
Closed -$523K – 116
2026
Q1 		$523K Sell
3,200
-50
-2% -$7.69K 0.13% 69
2025
Q4 		$566K Sell
3,250
-1,050
-24% -$192K 0.13% 80
2025
Q3 		$619K Sell
4,300
-2,180
-34% -$267K 0.12% 80
2025
Q2 		$652K Buy
+6,480
New +$495K 0.12% 74

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Pier 88 Investment Partners's INSM Position: Q2 2026 in Review

Pier 88 Investment Partners sold out of Insmed (INSM) in Q2 2026, closing a stake of 3,200 shares — an estimated $523K sold.

Pier 88 Investment Partners first reported a position in INSM in Q2 2025 and held it in 4 quarters. The position peaked at $652K in Q2 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Pier 88 Investment Partners reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Pier 88 Investment Partners sold 3,200 Insmed shares in Q2 2026, an estimated $523K.
  • Pier 88 Investment Partners first reported a position in Insmed in Q2 2025 and held it in 4 quarters.
  • Pier 88 Investment Partners's Insmed position peaked at $652K in Q2 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Pier 88 Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.